Zante Greg
- SEC CIK
- 0001264949
In the past year, 3 open-market sale filings worth $2.82M and no purchases.
Current role at each company
- VKTX Viking Therapeutics, Inc.Chief Financial Officeras of Jul 29, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $2.82M
- 3 filings
- Net
- −$2.82M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Zante Greg as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 29, 2026 (view filing)8:06 PM ET | Jul 29 | Same day | Zante GregChief Financial Officer | SSaleCommon Stock, par value $0.00001 per share | −21.2K | $33.47 | −$710.1K | −9.1%212.2K after | |
| Jan 5, 2026 (view filing) | Jan 5 | Same day | Zante GregChief Financial Officer | SSaleCommon Stock, par value $0.00001 per share | −57.7K | $32.90 | −$1.90M | −23.3%189.9K after | 4 lots |
| Oct 28, 2025 (view filing) | Oct 28 | Same day | Zante GregChief Financial Officer | SSaleCommon Stock, par value $0.00001 per share | −6.18K | $35.00 | −$216.5K | −3.4%173.6K after | |
| Jul 3, 2025 (view filing) | Jul 3 | Same day | Zante GregChief Financial Officer | SSaleCommon Stock, par value $0.00001 per share | −4.27K | $27.76 | −$118.4K | −2.5%168.7K after | |
| Jan 6, 2025 (view filing) | Jan 6 | Same day | Zante GregChief Financial Officer | SSaleCommon Stock, par value $0.00001 per share | −50.3K | $42.75 | −$2.15M | −23.3%165.3K after | 2 lots |
| Oct 28, 2024 (view filing) | Oct 28 | Same day | Zante GregChief Financial Officer | SSaleCommon Stock, par value $0.00001 per share | −131.7K | $76.62 | −$10.1M | −46.9%149.4K after | 8 lots10b5-1 |
| Jul 31, 2024 (view filing) | Jul 30 | 1 day | Zante GregChief Financial Officer | SSaleCommon Stock, par value $0.00001 per share | −16.1K | $57.15 | −$922.2K | −7.9%187.1K after | 3 lots |
| May 3, 2024 (view filing) | May 3 | Same day | Zante GregChief Financial Officer | SSaleCommon Stock, par value $0.00001 per share | −66.8K | $74.69 | −$4.99M | −27.6%174.9K after | 4 lots10b5-1 |
| Jan 4, 2024 (view filing) | Jan 4 | Same day | Zante GregChief Financial Officer | SSaleCommon Stock, par value $0.00001 per share | −15.0K | $17.90 | −$268.5K | −7.7%180.7K after | |
| Apr 18, 2023 (view filing) | Apr 17 | 1 day | Zante GregChief Financial Officer | SSaleCommon Stock, par value $0.00001 per share | −7.50K | $20.00 | −$150.0K | −4.8%149.3K after | |
| Apr 13, 2023 (view filing) | Apr 11-12 | 2 days | Zante GregChief Financial Officer | SSaleCommon Stock, par value $0.00001 per share | −97.8K | $18.00 | −$1.76M | −39.6%149.3K after | 2 lots |
| Apr 3, 2023 (view filing) | Mar 30-Apr 3 | 4 days | Zante GregChief Financial Officer | SSaleCommon Stock, par value $0.00001 per share | −161.9K | $17.19 | −$2.78M | −52.3%147.8K after | 2 lots |